Cargando…
Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy
Chagas disease cardiomyopathy is a parasite-driven inflammatory disease to which there are no effective treatments. Here we evaluated the therapeutic potential of N,N-dimethylsphingosine(DMS), which blocks the production of sphingosine-1-phosphate(S1P), a mediator of cellular events during inflammat...
Autores principales: | Vasconcelos, Juliana Fraga, Meira, Cássio Santana, Silva, Daniela Nascimento, Nonaka, Carolina Kymie Vasques, Daltro, Pâmela Santana, Macambira, Simone Garcia, Domizi, Pablo Daniel, Borges, Valéria Matos, Ribeiro-dos-Santos, Ricardo, de Freitas Souza, Bruno Solano, Soares, Milena Botelho Pereira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522404/ https://www.ncbi.nlm.nih.gov/pubmed/28733584 http://dx.doi.org/10.1038/s41598-017-06275-z |
Ejemplares similares
-
Sphingoid Bases Regulate the Sigma-1 Receptor—Sphingosine and N,N’-Dimethylsphingosine Are Endogenous Agonists
por: Li, Jing, et al.
Publicado: (2023) -
Tolerogenic Dendritic Cells Reduce Cardiac Inflammation and Fibrosis in Chronic Chagas Disease
por: Santos, Emanuelle de Souza, et al.
Publicado: (2020) -
Betulinic Acid Derivative BA5, Attenuates Inflammation and Fibrosis in Experimental Chronic Chagas Disease Cardiomyopathy by Inducing IL-10 and M2 Polarization
por: Meira, Cássio Santana, et al.
Publicado: (2019) -
Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity
por: Improta Caria, Alex Cleber, et al.
Publicado: (2018) -
Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2021)